Indian-Origin Woman Goes Cancer-Free After UK Experimental Drug Trial, Says She Feels “Reborn”
Cancer is the one medical condition that we’re all afraid of. Even to date, researchers haven’t been able to find the cause behind this condition but recently, there was a clinical trial at a UK hospital that created magic for an Indian-origin woman who was given just months to live a few years ago. But following the trial, doctors say that she is not showing any signs of breast cancer. The woman is currently looking forward to celebrating her 25th wedding anniversary with her husband in September after the successful trial at National Health Service (NHS) in London. Her trial lasted for two years.
As per media reports, the National Institute for Health and Care Research (NIHR), Manchester Clinical Research Facility (CRF) at Christie NHS Foundation Trust administered the woman, 51-year-old Jasmin David, an experimental medicine combined with an immunotherapy drug, Atezolizumab, intravenously which she continues to take every 3 weeks. Speaking to the media, the woman says that 15 months after her initial cancer treatment, she had almost forgotten about it when she had a relapse and was offered the trial. She shared that she wasn’t sure that it would work for her but she agreed to it thinking that she could at least do something and help others. She further added that she had several side effects of the cancer drug trial including headaches, and spiking temperatures and was in the hospital for a while. But soon she started responding to the treatment.
Also Read: 7 Ways To Reduce Your Risk Of Breast Cancer
Sharing her story, Jasmin David said that she found out about her breast cancer in November 2017 after she found a lump in her nipple and had to undergo 6 months of chemotherapy and a mastectomy in April 2018. This was followed by 15 cycles of radiotherapy which cleared her of cancer but she had a relapse in October 2019 when her scans showed multiple lesions throughout her body which meant that she had a poor prognosis. She shared that cancer had spread to her lungs, lymph nodes and chest bone and the doctors told her that she had less than a year to live with no other options left, she decided to take up the offer to be a part of the research by participating in Phase I clinical trials. She went on to add that 2.5 years ago, she thought it was the end but now she feels reborn.
First Published: July 05, 2022 1:10 PMCervical Cancer Awareness Month: Symptoms, Causes, Treatment, Everything You Need To Know About It
